Browse by category

Lab values predict periprosthetic joint infection in patients living with severe obesity

For patients with severe obesity undergoing knee or hip replacement, commonly obtained laboratory values - including markers of anaemia...

GSA publishes recommendations for the successful care of older adults with obesity

A summit convened by the Gerontological Society of America (GSA) has resulted in the identification of seven strategies for successful...

US Task Force recommends intensive, comprehensive behavioural interventions for children and teens with a high BMI

The US Preventive Services Task Force (Task Force) has posted a final recommendation statement on interventions for high body mass index...

OAC welcomes House Committee decision for advancing the Treat and Reduce Obesity Act

The Obesity Action Coalition (OAC) has welcomed the House Ways and Means Committee for favourably reporting an amended version of the...

First patient dosed NeuroBo Pharmaceuticals’ Phase 1 clinical trial evaluating DA-1726 for the treatment of obesity

NeuroBo Pharmaceuticals has dosed the first patient in the multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726,...

Vogenx announces positive results from second phase 2 study of mizagliflozin in post-bariatric hypoglycaemia

Vogenx has announced positive results from study VGX 001-012 evaluating mizagliflozin in patients diagnosed with post-bariatric...

Specific gut bacteria are involved in compulsive eating and obesity

An international team of researchers has identified specific bacteria in the gut that are associated with both mice and humans developing...

The role of patient outcomes in driving business success for bariatric clinics

Over the last few years, the demand for bariatric services has grown steadily - as more people have become aware of the risks that are...

Xeno Biosciences initiate phase 1b proof-of-concept study for obesity drug candidate XEN-101

Xeno Biosciences has initiated a Phase 1b clinical study designed to provide proof-of-concept weight loss results, along with safety and...

Specialist weight-loss services in England unable to keep up with spiralling demand

One in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

1 hour ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

2 hours ago

Racial and ethnic groups face barriers to obtaining OMMs

3 hours ago

Weekly Digest